Literature DB >> 19620232

Guidance values for surface monitoring of antineoplastic drugs in German pharmacies.

Rudolf Schierl1, Antje Böhlandt, Dennis Nowak.   

Abstract

OBJECTIVES: Antineoplastic drugs are widely used in anticancer therapy due to their cytotoxic activity but many of them are classified as carcinogenic, mutagenic, or teratogenic to humans. In order to evaluate personal exposure, surface monitoring has been successfully applied for several years. In this study, we present a statistical description of our data set from 102 German pharmacies and propose 'threshold guidance values (TGVs)' to facilitate interpretation of monitoring results.
METHODS: Our database included 1008 results for platinum (PT) and 1237 for 5-fluorouracil (FU) collected in 102 pharmacies in Germany. Wipe sampling on site was performed with one validated procedure. PT concentrations were measured by voltammetry and FU by gas chromatography/mass spectrometry. Data were stratified into 10 locations and statistically evaluated.
RESULTS: Contamination was detected on all surfaces in the pharmacies with high levels on storage shelves and floors. The median values for the different locations ranged from 0.20 to 1.70 pg cm(-2) (mean: 0.57 pg cm(-2)) for PT and from 2.50 to 10.00 pg cm(-2) (mean: 5.34 pg cm(-2)) for FU. The mean 75th percentiles were 3.92 pg cm(-2) (PT) and 28.90 pg cm(-2) (FU). The TGV 1 value was set at the median value and results below demonstrate good working practices. Contaminations above the TGV 2, which was assigned at the 75th percentile, show a clear need for optimizing the handling procedures.
CONCLUSIONS: The introduction of TGVs helps to reduce occupational exposure and allows pharmacy personnel to benchmark their own contamination levels. This provides a basis for improvement in occupational safety precautions and for regular contamination controls.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19620232     DOI: 10.1093/annhyg/mep050

Source DB:  PubMed          Journal:  Ann Occup Hyg        ISSN: 0003-4878


  20 in total

Review 1.  Reproductive health risks associated with occupational exposures to antineoplastic drugs in health care settings: a review of the evidence.

Authors:  Thomas H Connor; Christina C Lawson; Martha Polovich; Melissa A McDiarmid
Journal:  J Occup Environ Med       Date:  2014-09       Impact factor: 2.162

2.  Evaluation of working practices and surface contamination with antineoplastic drugs in outpatient oncology health care settings.

Authors:  Bettina Kopp; Rudolf Schierl; Dennis Nowak
Journal:  Int Arch Occup Environ Health       Date:  2012-02-05       Impact factor: 3.015

3.  Micronuclei and chromosome aberrations in subjects occupationally exposed to antineoplastic drugs: a multicentric approach.

Authors:  Massimo Moretti; Maria Giuseppa Grollino; Sofia Pavanello; Roberta Bonfiglioli; Milena Villarini; Massimo Appolloni; Mariella Carrieri; Laura Sabatini; Luca Dominici; Laura Stronati; Giuseppe Mastrangelo; Anna Barbieri; Cristina Fatigoni; Giovanni Battista Bartolucci; Elisabetta Ceretti; Francesca Mussi; Silvano Monarca
Journal:  Int Arch Occup Environ Health       Date:  2014-11-02       Impact factor: 3.015

Review 4.  Environmental monitoring by surface sampling for cytotoxics: a review.

Authors:  Petit Marie; Curti Christophe; Roche Manon; Montana Marc; Bornet Charleric; Vanelle Patrice
Journal:  Environ Monit Assess       Date:  2017-01-06       Impact factor: 2.513

5.  Multicenter study of environmental contamination with antineoplastic drugs in 33 Canadian hospitals.

Authors:  Delphine Merger; Cynthia Tanguay; Eric Langlois; Michel Lefebvre; Jean-François Bussières
Journal:  Int Arch Occup Environ Health       Date:  2013-03-08       Impact factor: 3.015

6.  Antineoplastic drugs contamination of workplace surfaces in two Portuguese hospitals.

Authors:  Susana Viegas; Mário Pádua; Ana Costa Veiga; Elisabete Carolino; Mário Gomes
Journal:  Environ Monit Assess       Date:  2014-08-06       Impact factor: 2.513

7.  Surface wipe sampling for antineoplastic (chemotherapy) and other hazardous drug residue in healthcare settings: Methodology and recommendations.

Authors:  Thomas H Connor; Matthew D Zock; Amy H Snow
Journal:  J Occup Environ Hyg       Date:  2016-09       Impact factor: 2.155

Review 8.  Meta-analysis of chromosomal aberrations as a biomarker of exposure in healthcare workers occupationally exposed to antineoplastic drugs.

Authors:  Christine Roussel; Kristine L Witt; Peter B Shaw; Thomas H Connor
Journal:  Mutat Res Rev Mutat Res       Date:  2017-08-24       Impact factor: 5.657

Review 9.  A review of high performance liquid chromatographic-mass spectrometric urinary methods for anticancer drug exposure of health care workers.

Authors:  Patricia I Mathias; Thomas H Connor; Clayton B'Hymer
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2017-06-19       Impact factor: 3.205

10.  Reduction in Surface Contamination With Cyclophosphamide in 30 US Hospital Pharmacies Following Implementation of a Closed-System Drug Transfer Device.

Authors:  Paul J M Sessink; Jason Trahan; Joseph W Coyne
Journal:  Hosp Pharm       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.